{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:08:26Z","timestamp":1788995306460,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016981","name":"Pharmaceutical Society of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K17479"],"award-info":[{"award-number":["23K17479"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejps.2026.107645","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:27:42Z","timestamp":1787095662000},"page":"107645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells"],"prefix":"10.1016","volume":"226","author":[{"given":"Makoto","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riku","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiemi","family":"Matsuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Matsuo-Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8765-2463","authenticated-orcid":false,"given":"Shigeru","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107645_bib0001","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2026.107645_bib0002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2019.05.010","article-title":"Ligand density on nanoparticles: a parameter with critical impact on nanomedicine","volume":"143","author":"Alkilany","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107645_bib0003","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1039\/D1NA00696G","article-title":"Quantifying the effect of PEG architecture on nanoparticle ligand availability using DNA-PAINT","volume":"3","author":"Andrian","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ejps.2026.107645_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/0005-2736(93)90039-3","article-title":"Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times","author":"Blume","year":"1993","journal-title":"BBA-Biomembr."},{"key":"10.1016\/j.ejps.2026.107645_bib0005","first-page":"14","article-title":"PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets","author":"Bruckner","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107645_bib0006","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/acsnanoscienceau.5c00170","article-title":"Decoupling physisorption from chemisorption in clickable lipid nanoparticles","volume":"6","author":"Brysgel","year":"2026","journal-title":"ACS Nanosci. Au"},{"key":"10.1016\/j.ejps.2026.107645_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102520","article-title":"Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers","volume":"36","author":"Dietmair","year":"2025","journal-title":"Mol. Ther. Nucleic. Acids"},{"key":"10.1016\/j.ejps.2026.107645_bib0008","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","article-title":"In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles","volume":"9","author":"Hadjidemetriou","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2026.107645_bib0009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejps.2018.07.036","article-title":"Synthesis of high functionality and quality mannose-grafted lipids to produce macrophage-targeted liposomes","volume":"123","author":"Hagimori","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107645_bib0010","article-title":"Rapid modification of antibodies on the surface of liposomes composed of high-affinity protein A-conjugated phospholipid for selective drug delivery","volume":"27","author":"Hama","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.ejps.2026.107645_bib0011","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2026.107645_bib0012","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejps.2026.107645_bib47","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.3390\/pharmaceutics14112357","article-title":"Stability study of mRNA-lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability","volume":"14","author":"Kamiya","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107645_bib0013","doi-asserted-by":"crossref","first-page":"15191","DOI":"10.1021\/acsnano.1c05713","article-title":"Density of conjugated antibody determines the extent of Fc receptor-dependent capture of nanoparticles by liver sinusoidal endothelial cells","volume":"15","author":"Kappel","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2026.107645_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114468","article-title":"Synthesis of a novel adapter lipid using Fc-region mediated antibody modification for post-insert preparation of transferrin receptor targeted messenger RNA-loaded lipid nanoparticles","volume":"203","author":"Kato","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107645_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106239","article-title":"Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: application of cyclic RGD peptide","volume":"176","author":"Kato","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107645_bib0016","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local administration in mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107645_bib0017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/bi962148u","article-title":"Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro","volume":"36","author":"Kirpotin","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2026.107645_bib0018","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2012.02.009","article-title":"Analysis of cause of failure of new targeting peptide in PEGylated liposome: molecular modeling as rational design tool for nanomedicine","volume":"46","author":"Lehtinen","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107645_bib0019","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.2147\/IJN.S144184","article-title":"Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells","volume":"12","author":"Li","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2026.107645_bib0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/acsnanomed.6c00043","article-title":"Lipid nanoparticle-mediated systemic RNA delivery to the spleen: strategies, applications, and challenges","volume":"1","author":"Li","year":"2026","journal-title":"ACS Nano Med."},{"key":"10.1016\/j.ejps.2026.107645_bib46","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2026.107645_bib0021","first-page":"15","article-title":"Lipid nanoparticles functionalized with antibodies for anticancer drug therapy","author":"Marques","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107645_bib0022","first-page":"17","article-title":"Targeted delivery of VEGF-siRNA to glioblastoma using orientation-controlled anti-PD-L1 antibody-modified lipid nanoparticles","author":"Matsuo-Tani","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107645_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100450","article-title":"Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics","volume":"44","author":"Mukai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107645_bib0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr1612","article-title":"HER2 therapy: molecular mechanisms of trastuzumab resistance","volume":"8","author":"Nahta","year":"2006","journal-title":"Breast. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107645_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2026.107645_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.882363","article-title":"Understanding the role and impact of poly (ethylene glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines","volume":"10","author":"Padin-Gonzalez","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejps.2026.107645_bib0027","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/acsnano.4c16562","article-title":"Apolipoprotein fusion enables spontaneous functionalization of mRNA lipid nanoparticles with antibody for targeted cancer therapy","volume":"19","author":"Park","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2026.107645_bib0028","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ymthe.2019.05.012","article-title":"mRNA delivery for therapeutic anti-HER2 antibody expression in vivo","volume":"27","author":"Rybakova","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2026.107645_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.01.016","article-title":"Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection","volume":"167","author":"Sharma","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2026.107645_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107645_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2017.02.041","article-title":"Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: the effect of serine-glycine repeated peptides as a spacer","volume":"521","author":"Suga","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107645_bib0031","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2191891","article-title":"Investigation of enhanced intracellular delivery of nanomaterials modified with novel cell-penetrating zwitterionic peptide-lipid derivatives","volume":"30","author":"Sugimoto","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107645_bib0032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107645_bib0033","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejps.2026.107645_bib0034","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2468-2667(24)00156-7","article-title":"Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data","volume":"9","author":"Sung","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ejps.2026.107645_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2026.107645_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121741","article-title":"A robust post-insertion method for the preparation of targeted siRNA LNPs","volume":"620","author":"Swart","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107645_bib0037","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1038\/s41598-018-24968-x","article-title":"Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells","volume":"8","author":"Truffi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107645_bib0038","first-page":"11","article-title":"Nanotechnology approaches to addressing HER2-positive breast cancer","author":"White","year":"2020","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ejps.2026.107645_bib0039","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2026.107645_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101463","article-title":"Lipid nanoparticles: composition, formulation, and application","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ejps.2026.107645_bib0041","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","article-title":"Surface modification of lipid-based nanoparticles","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2026.107645_bib0042","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.omtn.2022.09.010","article-title":"Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.ejps.2026.107645_bib0043","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.03.081","article-title":"Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery","volume":"487","author":"Zhou","year":"2015","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:38:48Z","timestamp":1788993528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S0928098726002198"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107645","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107645"}}